Fig. 2From: Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011–2017Cumulative incidence curves from competing risk analyses of first regimen discontinuation for intolerance/toxicity by regimen typeBack to article page